Antagonistic effects of PU.1 on Gfi-1B-induced erythroid colony formation in human cord blood cells
Cellular and Molecular Biology · 2025
DOI: 10.14715/cmb/2025.71.3.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2025. Verfasst von Noriyoshi Manabe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Structural Glycobiology Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins, Fetal Blood, Trans-Activators, DNA-Binding Proteins. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Gfi-1B is a hematopoietic transcription factor essential for growth and differentiation of the erythroid/megakaryocytic lineages, and PU.1 is a master regulator for myeloid development. Herein, we demonstrate that PU.1 interacted with Gfi-1B in vivo by immunoprecipitation assay. GST pull-down assays showed that the binding sites were located in the Ets domain of PU.1 and the zinc finger domain of Gfi-1B. Luciferase reporter assays revealed that PU.1 and Gfi-1B antagonized each other's transcriptional activity in a dose-dependent manner. The transduction of Gfi-1B alone in human cord blood progenitor cells strongly enhanced erythroid colony formation. However, the transduction of PU.1 along with Gfi-1B in the progenitors significantly inhibited erythroid colony formation. Co-expression of Gfi-1B with a mutant PU.1, which bound to Gfi-1B but not to GATA1, another erythroid master regulator, also inhibited Gfi-1B-induced erythroid colony formation. Our results suggest that the function of Gfi-1B in the growth and differentiation of erythroid cells is antagonized by the expression of PU.1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Structural Glycobiology Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan. manabe@tohoku-mpu.ac.jp.
- Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama, Japan. t-sakurai@nichiyaku.ac.jp.
- Department of Life and Health Sciences, School of Pharma-Sciences, Teikyo University, Tokyo, Japan. fumikokn@pharm.teikyo-u.ac.jp.
- Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, Tokyo, Japan. nakazawa-ys@pha.keio.ac.jp.
- Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama, Japan. t-yamada@nichiyaku.ac.jp.
- Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. 03aiwama@ims.u-tokyo.ac.jp.
Zitieren
APA
Manabe, N., Sakurai, T., Kihara-Negishi, F., Nakazawa, Y., Yamada, T., Iwama, A., & Oikawa, T. (2025). Antagonistic effects of PU.1 on Gfi-1B-induced erythroid colony formation in human cord blood cells. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2025.71.3.6
Vancouver
Manabe N, Sakurai T, Kihara-Negishi F, Nakazawa Y, Yamada T, Iwama A, et al. Antagonistic effects of PU.1 on Gfi-1B-induced erythroid colony formation in human cord blood cells. Cellular and Molecular Biology. 2025. doi:10.14715/cmb/2025.71.3.6
BibTeX
@article{Manabe2025,
author = {Manabe, Noriyoshi and Sakurai, Takuya and Kihara-Negishi, Fumiko and Nakazawa, Yosuke and Yamada, Toshiyuki and Iwama, Atsushi and Oikawa, Tsuneyuki},
title = {Antagonistic effects of PU.1 on Gfi-1B-induced erythroid colony formation in human cord blood cells},
journal = {Cellular and Molecular Biology},
year = {2025},
doi = {10.14715/cmb/2025.71.3.6}
}
EUVIMED